Evidence map›Paper›PMID 35078847›Full record

ArticleBMJ open2022

Study protocol for monitoring SARS-CoV-2 infection and its determinants in Catalonia (Spain): an observational and participatory research approach in a Sentinel Network of Schools.

Anna Bordas, Antoni Soriano-Arandes, Maria Subirana, Rosina Malagrida, Juliana Maria Reyes-Urueña, Cinta Folch, Pere Soler-Palacin, Mireia Gascón, Jordi Sunyer, Andres Anton and 8 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Anna BordasCentre for Epidemiological Studies of HIV/SIDA and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Badalona, Catalunya, Spain.ORCID 0000-0001-5640-8433
Antoni Soriano-ArandesPediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron, Barcelona, Catalunya, Spain.
Maria SubiranaBarcelona Institut for Global Health, IMIM-Parc Salut Mar, Barcelona, Catalunya, Spain.
Rosina MalagridaLiving Lab for Health, IrsiCaixa AIDS Research Institute, Badalona, Catalunya, Spain.
Juliana Maria Reyes-UrueñaCentre for Epidemiological Studies of HIV/SIDA and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Badalona, Catalunya, Spain.ORCID 0000-0002-3122-6518
Cinta FolchCentre for Epidemiological Studies of HIV/SIDA and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Badalona, Catalunya, Spain.
Pere Soler-PalacinPediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron, Barcelona, Catalunya, Spain.
Mireia GascónUniversitat Pompeu Fabra, Barcelona, Catalunya, Spain.
Jordi SunyerUniversitat Pompeu Fabra, Barcelona, Catalunya, Spain.
Andres AntonMicrobiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Institut Català de la Salut, Barcelona, Catalunya, Spain.
Ignacio BlancoMicrobiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Institut D'Investigació en Ciències de La Salut Germans Trias I Pujol (IGTP), Institut Català de la Salut, Barcelona, Catalunya, Spain.
Jessica Fernández-MoralesLiving Lab for Health, IrsiCaixa AIDS Research Institute, Badalona, Catalunya, Spain.
Andreu Colom-CadenaCentre for Epidemiological Studies of HIV/SIDA and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Badalona, Catalunya, Spain.
Alexis SentísCentre for Epidemiological Studies of HIV/SIDA and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Badalona, Catalunya, Spain.
Tomas PumarolaMicrobiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Institut Català de la Salut, Barcelona, Catalunya, Spain.
Josep BasoraFoundation University Institute for Research in Primary Health Care Jordi Gol i Gurina (IDIAP Jordi Gol), Barcelona, Catalunya, Spain.
Jordi CasabonaCentre for Epidemiological Studies of HIV/SIDA and STI of Catalonia (CEEISCAT), Health Department, Generalitat de Catalunya, Badalona, Catalunya, Spain jcasabona@iconcologia.net.
Sentinel School Network Study Group of Catalonia
Generalitat de Catalunya · ESUniversitat Autònoma de Barcelona · ESUniversitat Pompeu Fabra · ESIrsiCaixa · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESPrimary HealthCare · MT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSince the SARS-CoV-2 became of concern in January 2020, many preventive measures have been adopted in educational settings to ensure the control of COVID-19 pandemic among children and staff in schools. This study aims to set up a school sentinel surveillance network with the purpose of monitoring SARS-CoV-2 infection, seroprevalence as well as to analyse the impact of preventive interventions of SARS-CoV-2 in school settings. Additionally, we will assess diverse screening strategies in a cohort of students and school staff to monitor the screening acceptance and its potential impact. Altogether, we hope this study will enable the design of more effective strategies for the prevention of COVID-19 spread. METHODS AND ANALYSIS: The sentinel schools' study is a cross-sectional, school-based project including 26 participating sentinel schools in Catalonia (Spain). Children, adolescents and staff at the schools will be invited to participate. This project will be carried out from January 2021 to June 2022 as follows: (1) twice yearly serological testing and molecular SARS-CoV-2 detection and questionnaires covering SARS-CoV-2 symptoms, tests, health, knowledge, attitudes and behaviours; (2) an environmental evaluation carried out in different classrooms; (3) SARS-CoV-2 transmission dynamics and the impact of different variants among confirmed cases and classmates; (4) a participatory process by which the participants are invited to act as coinvestigators to evaluate prevention strategies and provide recommendations to improve COVID-19 prevention in schools. Descriptive analysis will be performed for the main variables collected. The incidence and seroprevalence will be calculated and the association with sociodemographic factors and school characteristics will be determined using multivariate logistic regression. ETHICS AND DISSEMINATION: Ethical approval was obtained from the IDIAPJGol and the Hospital Universitari Vall d'Hebron ethics committees. A report will be generated quarterly. Findings will be disseminated at national and international conferences and published in peer-reviewed journals.

Indexed as

COVID-19AdolescentChildCommunity-Based Participatory ResearchCross-Sectional StudiesHumansObservational Studies as TopicPandemicsSARS-CoV-2SchoolsSeroepidemiologic StudiesSociodemographic FactorsSpaincommunity child healthCOVID-19epidemiologypublic health

Identifiers

PMID35078847
PMCPMC8795925
OpenAlexW4206957691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.